SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Cellebrite DI Ltd. (CLBT) trades at a trailing P/E of 43.4, forward P/E of 32.2. Trailing earnings yield is 2.31%, forward earnings yield 3.10%. PEG 1.72. Graham Number is $3.48.
Criteria proven by this page:
- VALUE (49/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 32.2 (down from trailing 43.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.72 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 2.31% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.10% as earnings recover.
- Analyst consensus target $20.67 (+74.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 71/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
49/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CLBT
Valuation Multiples
P/E (TTM)43.4
Forward P/E32.2
PEG Ratio1.72
Forward PEG1.72
P/B Ratio7.02
P/S Ratio6.70
EV/EBITDA36.9
Per Share Data
EPS (TTM)$0.29
Forward EPS (Est.)$0.37
Book Value / Share$1.82
Revenue / Share$1.79
FCF / Share$0.59
Yields & Fair Value
Earnings Yield2.31%
Forward Earnings Yield3.10%
Dividend Yield0.00%
Graham Number$3.48
SharesGrow IV$55.26 (+365.9%)
Analyst Target$20.67 (+74.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-963.8 |
0.00 |
30.73 |
10.52 |
1.38% |
| 2020 |
340.9 |
-0.83 |
30.89 |
10.11 |
0.51% |
| 2021 |
16.2 |
0.01 |
-15.75 |
4.69 |
8.66% |
| 2022 |
6.6 |
0.24 |
10.78 |
2.94 |
- |
| 2023 |
-20.3 |
0.12 |
48.13 |
5.07 |
- |
| 2024 |
-16.3 |
-0.08 |
13.73 |
11.50 |
- |
| 2025 |
58.2 |
-0.47 |
9.41 |
9.58 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.01 |
$171.85M |
$-1.88M |
-1.1% |
| 2020 |
$0.05 |
$194.91M |
$5.78M |
3% |
| 2021 |
$0.44 |
$246.25M |
$71.4M |
29% |
| 2022 |
$0.59 |
$270.65M |
$120.81M |
44.6% |
| 2023 |
$-0.43 |
$325.11M |
$-81.1M |
-24.9% |
| 2024 |
$-1.35 |
$401.2M |
$-283.01M |
-70.5% |
| 2025 |
$0.31 |
$475.68M |
$78.33M |
16.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.37 |
$0.36 – $0.38 |
$568.47M |
$567.12M – $569.32M |
4 |
| 2027 |
$0.45 |
$0.44 – $0.47 |
$665.38M |
$654.11M – $681.73M |
3 |
| 2028 |
$0.58 |
$0.57 – $0.59 |
$771.95M |
$771.91M – $771.99M |
2 |
| 2029 |
$0.90 |
$0.89 – $0.92 |
$863.4M |
$855.06M – $876.9M |
1 |
